Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D002450:Cell Communication; D002465:Cell Movement; D002471:Cell Transformation, Neoplastic / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D005354:Fibrosarcoma / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive; D008081:Liposomes / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000556:secondary; D008222:Lymphokines / Q000627:therapeutic use; D008223:Lymphoma / Q000556:secondary; D008262:Macrophage Activation; D008264:Macrophages / Q000187:drug effects / Q000276:immunology / Q000502:physiology; D008545:Melanoma / Q000276:immunology / Q000628:therapy; D051379:Mice; D009362:Neoplasm Metastasis / Q000628:therapy*
D000276:Adjuvants, Immunologic; D008081:Liposomes; D008222:Lymphokines; D000119:Acetylmuramyl-Alanyl-Isoglutamine